GGrantIndex
← Leaderboards

Yi-Fen Lee

University Of Rochester

$4,026,830
Attributed
$4,026,830
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $449.3K · FY200825
$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,026,830 · 3

By mechanism

R01$4,026,830 · 3

Top collaborators

No co-investigators on record.

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsMediatingGenesCellsAffectCancer PatientMolecularPathway InteractionsPreventMolecular ProfilingNovel DiagnosticsKnock-DownCell ProliferationLeadSignal TransductionTumorBehaviorElderlyDisease ProgressionDiagnosisCancer CellMalignant NeoplasmsBiologicalTumorigenesis

Grant awards (12)

Clinical and pre-clinical investigation of extracellular vesicles as a mechanism of toxicity in the bladder of prostate cancer patients treated with radiotherapy$431,650
R01 · FY2025 · CA · contact PI
Clinical and pre-clinical investigation of extracellular vesicles as a mechanism of toxicity in the bladder of prostate cancer patients treated with radiotherapy$449,295
R01 · FY2024 · CA · contact PI
Exosomes: A novel mechanism for bladder cancer tumorigenesis and progression$376,236
R01 · FY2018 · CA · contact PI
Exosomes: A novel mechanism for bladder cancer tumorigenesis and progression$376,236
R01 · FY2017 · CA · contact PI
Exosomes: A novel mechanism for bladder cancer tumorigenesis and progression$365,944
R01 · FY2016 · CA · contact PI
Exosomes: A novel mechanism for bladder cancer tumorigenesis and progression$346,833
R01 · FY2015 · CA · contact PI
Exosomes: A novel mechanism for bladder cancer tumorigenesis and progression$346,833
R01 · FY2014 · CA · contact PI
TR4 orphan receptor, a longevity assurance gene, in prostate carcinogenesis$261,900
R01 · FY2012 · CA · contact PI
TR4 orphan receptor, a longevity assurance gene, in prostate carcinogenesis$261,900
R01 · FY2011 · CA · contact PI
TR4 orphan receptor, a longevity assurance gene, in prostate carcinogenesis$270,001
R01 · FY2010 · CA · contact PI
TR4 orphan receptor, a longevity assurance gene, in prostate carcinogenesis$270,001
R01 · FY2009 · CA · contact PI
TR4 orphan receptor, a longevity assurance gene, in prostate carcinogenesis$270,001
R01 · FY2008 · CA · contact PI